Impact of vitamin D supplementation on cardio-metabolic status and androgen profile in women with polycystic ovary syndrome: placebo-controlled clinical trial

Middle East Fertility Society Journal

Table 4 logistic regression analysis evaluating the association of cardio-metabolic risk and androgenic markers with VD supplementation among PCOS women

	Unstandardized coefficients		Odds ratio	95% C.I.		t	P value
	β	Standard error	Odds ratio	Lower bound	Upper bound	t	P value
Constant	− 68.191	47.583	0.000		2.035	2.054	0.152
SHBG	0.001	0.032	1.001	0.941	1.065	0.001	0.973
Androstenedione	− 1.374	0.485	0.253	0.098	0.654	8.038	˂ 0.05*
Free testosterone	0.104	0.369	1.109	0.539	2.284	0.079	0.779
Systolic BP	− 0.092	0.158	0.912	0.669	1.243	0.342	0.559
Diastolic BP	0.164	0.152	1.179	0.876	1.587	1.175	0.278
Total cholesterol	− 0.030	0.119	0.971	0.769	1.224	0.064	0.801
LDL cholesterol	0.029	0.123	1.030	0.809	1.311	0.057	0.811
HDL cholesterol	− 0.129	0.153	0.879	0.651	1.187	0.708	0.400
FPG	0.764	0.504	2.146	0.799	5.764	2.294	0.130
FSI	0.182	0.091	1.199	1.004	1.433	4.017	˂ 0.05*
Hirsutism score	0.285	0.156	1.330	0.981	1.804	3.366	˂ 0.05*